Oncology
🇺🇸 FDA Page 9FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 97–108 of 246 articles
Perimeter Medical's Claire OCT+AI Receives FDA Approval for Breast Cancer Surgery Margin Assessment
FDA Accelerated Approvals Oncology: 2026 Policy Review & Zongertinib Case
KRAS G12C Inhibitors NSCLC: Market Analysis of Sotorasib & Adagrasib
FDA Approval Elranatamab: Efficacy, Safety & Market Impact in RRMM
Clinical Outsourcing: Key Takeaways from 2026 Trends
Tempest Therapeutics TPST-2003 CAR-T Shows Promise for Multiple Myeloma at ISCT 2026
Pfizer's ELREXFIO Shows Significant Progression-Free Survival Improvement in Multiple Myeloma Phase 3 Trial
Laguna Biotherapeutics Receives FDA Clearance for LGNA-100 Pediatric Leukemia Trial
COG 2024: Daily Highlights and Key Takeaways
FDA Accelerated Approval Reforms: What You Need to Know for Oncology Market Access 2026
SFDA Accelerated Approval Oncology: Impact on Innovative Drugs in Saudi Arabia
Adagrasib Phase 3 Trial Results: Key Insights on KRAS G12C NSCLC